SB 202190 Detalles del Producto Nùmero de Catalogo 1523072 Descripcion SB 202190 is a selective and potent p38 MAP kinases inhibitor, binding to its ATP pocket. It has negligible inhibiting properties on other MAP kinases such as ERKs and JNKs. SB 202190 is reported to be used to induce cardiomyocyte differentiation from human embryonic stem cells and increase neural stem cell self-renewal. Synonyms: SB-202190, SB202190, FHPI, 4-[4-(4-Fluorphenyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]phenol Application: Formulation: Crystalline solid Chemical Name: 4-[4-(4-fluorophenyl)-5-pyridin-4-yl-1,3-dihydroimidazol-2-ylidene]cyclohexa-2,5-dien-1-one Molecular Formula: C20H14FN3O Molecular Weight: 331.3 CAS Number: 152121-30-7 Purity: ≥98% Note: Product supplied by Biogems Research Interest Stem Cells & Differentiation Product Line Country Of Origin: USA Not for human use.
